| Overview |
| bs-1311R-Cy5.5 |
| LYVE-1 Polyclonal Antibody, Cy5.5 Conjugated |
| WB |
| Human, Mouse |
| Rat |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from mouse LYVE-1 |
| 231-318/318 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 114332 |
| Q8BHC0 |
| Cytoplasm, Cell membrane, Extracellular matrix |
| Xlkd1; Lyve-1; Crsbp-1; 1212G8Rik; Lymphatic vessel endothelial hyaluronic acid receptor 1; Cell surface retention sequence-binding protein 1; Extracellular link domain-containing protein 1; Lyve1; Crsbp1 |
| Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as a hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz